We first report the largest cohort of Chinese patients with CLAH.
Our patients had classic features at onset and responded well to the treatment.
Totally eleven STAR gene mutations containing five novel variants were identified.
All the novel variants of the STAR gene were predicted to be pathogenic in silico.
We found two possible founder mutations in Chinese population.